A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Clinical trial NCT05299359 · COMPLETED

Trial details

NCT number: NCT05299359
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronavirus Disease (COVID-19)

Start date: 2022-04-15
Primary completion: 2022-06-11
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.